ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, presenting promising advancements across various health-related and industrial apps. With its structural similarity to In a natural way derived human serum albumin, OsrHSA provides a safer, much more reliable choice for therapeutic